NO983373L - Medication system for in situ constitution for release of enzymes into wounds - Google Patents

Medication system for in situ constitution for release of enzymes into wounds

Info

Publication number
NO983373L
NO983373L NO983373A NO983373A NO983373L NO 983373 L NO983373 L NO 983373L NO 983373 A NO983373 A NO 983373A NO 983373 A NO983373 A NO 983373A NO 983373 L NO983373 L NO 983373L
Authority
NO
Norway
Prior art keywords
wounds
enzymes
situ
constitution
release
Prior art date
Application number
NO983373A
Other languages
Norwegian (no)
Other versions
NO983373D0 (en
Inventor
Uwe Loeffler
Thomas Moest
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of NO983373D0 publication Critical patent/NO983373D0/en
Publication of NO983373L publication Critical patent/NO983373L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Det er beskrevet et system for utvendig påførbare aktivsubstanser som er , yannfølsomme og som dårlig absorberes av geleringsmidler. Systemet karakteriseres ved at det omfatter (1) et kammer for den aktive substans, (2) et kammer for et løsningsmiddel som den aktive substans er løselig i og (3) et kammer for et geleringsmiddel. Kammerne er slik utformet at de sikrer at deres respektive innhold vil blande seg hurtig med hverandre.A system for externally applied active substances is disclosed which is, insensitive and poorly absorbed by gelling agents. The system is characterized in that it comprises (1) a chamber for the active substance, (2) a chamber for a solvent in which the active substance is soluble and (3) a chamber for a gelling agent. The chambers are designed to ensure that their respective contents will blend in with one another quickly.

NO983373A 1996-01-23 1998-07-22 Medication system for in situ constitution for release of enzymes into wounds NO983373L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19602208A DE19602208A1 (en) 1996-01-23 1996-01-23 Pharmaceutical form formed in situ for the delivery of enzymes to wounds
PCT/EP1997/000284 WO1997026861A1 (en) 1996-01-23 1997-01-22 Medicament forms constituted in situ for releasing enzymes into wounds

Publications (2)

Publication Number Publication Date
NO983373D0 NO983373D0 (en) 1998-07-22
NO983373L true NO983373L (en) 1998-09-21

Family

ID=7783390

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983373A NO983373L (en) 1996-01-23 1998-07-22 Medication system for in situ constitution for release of enzymes into wounds

Country Status (14)

Country Link
EP (1) EP0876139A1 (en)
JP (1) JP2001518063A (en)
KR (1) KR19990081901A (en)
CN (1) CN1209739A (en)
AU (1) AU715587B2 (en)
BR (1) BR9707058A (en)
CA (1) CA2243528A1 (en)
CZ (1) CZ230198A3 (en)
DE (1) DE19602208A1 (en)
HU (1) HUP9900942A3 (en)
IL (1) IL125148A (en)
NO (1) NO983373L (en)
WO (1) WO1997026861A1 (en)
ZA (1) ZA97514B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2194144B (en) * 1986-08-22 1990-04-25 American Cyanamid Co Stable pharmaceutical gel preparation
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof

Also Published As

Publication number Publication date
JP2001518063A (en) 2001-10-09
HUP9900942A3 (en) 2000-06-28
HUP9900942A2 (en) 1999-08-30
AU1544297A (en) 1997-08-20
WO1997026861A1 (en) 1997-07-31
ZA97514B (en) 1998-07-22
CZ230198A3 (en) 1999-02-17
EP0876139A1 (en) 1998-11-11
CA2243528A1 (en) 1997-07-31
AU715587B2 (en) 2000-02-03
DE19602208A1 (en) 1997-07-24
KR19990081901A (en) 1999-11-15
CN1209739A (en) 1999-03-03
IL125148A0 (en) 1999-01-26
IL125148A (en) 2001-03-19
NO983373D0 (en) 1998-07-22
BR9707058A (en) 1999-07-20

Similar Documents

Publication Publication Date Title
TR200100366T2 (en) Compounds and compositions for dispensing the active substance.
BR9804500B1 (en) amide derivative, said pharmaceutical composition and therapeutic agent.
ES2115298T3 (en) NEW DERIVATIVES OF 1-PHENYL-3-DIMETHYL-AMINO-PROPANE, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
TR199900083T2 (en) Crystal form of clarithromycin I.
NO20001042L (en) Ophthalmic delayed release preparations containing water-soluble drugs
BR9707336A (en) Continuous dosing of an active agent using an implantable system
BR9607414A (en) Use of inorganic aerogels in pharmacology
HUP0004421A3 (en) Urea derivatives and pharmaceutical compositions containing them, use thereof for the treatment of deseases mediated by impdh enzyme
AU6607898A (en) Transdermal therapeutic system
DK1117645T3 (en) Aryl-substituted propanolamine derivatives, processes for their preparation, drugs containing these compounds and their use
BR9607772A (en) Hydroxamic acid derivatives containing lactam its preparation and its use as matrix metalloprotease inhibitors
FR2774909B1 (en) PHARMACEUTICAL FORMULATION, PERFUSION SOLUTION AND LYOPHILIZED COMPOSITION COMPRISING AN EPOTHILONE.
NL300109I1 (en) Crystal modification of CDCH, process for its preparation and of pharmaceutical preparations containing these modifications.
MXPA02010648A (en) Liquid formulations.
NO934706L (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines
PT1220685E (en) PHARMACEUTICAL COMPOSITIONS OF A FIBRINOLITIC AGENT
BR0013012A (en) Composition containing active substance, its production and use
AP2003002716A0 (en) Medicinal compositions containing propenone derivatives.
WO2001083398A3 (en) System for the release of active ingredients
NO972449L (en) Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one-1,1-dioxide derivatives and preparations and process for use thereof
IS5390A (en) Benzoxazine and benzothiazine derivatives and their use in medicine
FR2705963B1 (en) Sulfonated derivatives of cyclomalto-oligosaccharides, process for their preparation and support for active substances containing these derivatives.
BG101080A (en) Medicamentous form of carbamasepin with delayed release of the active substance
EP0391852A3 (en) Pharmaceutical compositions
DK0806949T3 (en) New pharmaceutical composition containing trimebutin and process for its preparation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application